Abstract

We aim to evaluate the symptoms, psychological burden and sexual dysfunction in men with chronic prostatitis/ chronic pelvic pain syndrome. An observational, cross-sectional and multicenter survey was conducted from July 2012 to January 2014. Male participants were recruited from urology clinics in five cities in China. Patients were asked to participate the survey by completing a verbal questionnaire, which consisted of social-demographics, sexual history, expressed prostatic secretions evaluation and score of the National Institute of Health Chronic Prostatitis Symptom Index (NIH-CPSI). A total of 1,280 men (their mean ages were 34.50 ± 9.20 years) completed the survey. The incidences of CP/CPPS type III a and III b in men with CP/CPPS (N=801) were 31.71% and 68.29%, respectively. Significantly differences on NIH-CPSI scores, and the incidence of psychological burden and sexual dysfunction were observed between CP/CPPS and control groups. Similarly, men with the CP/CPPS type III a vs. type III b reported higher scores of NIH-CPSI, and higher incidence of psychological burden and sexual dysfunction (P<0.001 for all). Logistic regression analyses showed that CP/CPPS was significantly associated with NIH-CPSI scores, including total scores >20 (OR:3.82, CI:2.21 -4.25), pain symptoms >10 (OR:3.89, CI:3.15-5.48), urinary symptoms (OR:3.15, CI:2.96-4.07) and QOL impact (OR:2.54, CI: 1.82-2.88). In addition, CP/CPPS associated with psychological burden (Anxiety:[OR:2.24, CI:1.57-2.69]; Depression:[OR:2.04, CI:1.33-2.71]; Loss of sleep:[OR:1.56, CI:1.03-3.35]; Decline in memory:[OR:1.87, CI:1.45-2.36]) and sexual dysfunction (PE:[OR:2.13, CI:1.25-3.67]; ED:[OR:1.85-1.38-3.32]; Decline in sexual desire:[OR:1.64, CI:1.27-3.25]).

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call